关于治疗紫外线炎的SER建议
Emma Beltrán Catalán1, Noé Brito García2, Esperanza Pato Cour3
1Servicio de Reumatología, Hospital del Mar, Barcelona, Spain.
Reumatologia clinica
|October 15, 2023
概括
这项研究提出了专家共识的建议,用于管理非传染性脑膜炎. 这些指导方针旨在标准化西班牙的非新发性,非脱血性疾病相关的胰腺炎的治疗方法.
科学领域:
- 眼科医生 眼科 眼科
- 类风湿病学 类风湿病学
- 临床医学 临床医学
背景情况:
- 尿道炎是一种导致眼内炎症的疾病,可能与各种系统性疾病有关.
- 非传染性,非新生病性和非去乙烯化病因代表了需要特定管理策略的重要子集.
- 缺乏标准化的治疗指南可能会导致患者护理的变化.
研究的目的:
- 建立基于证据的,专家共识的建议,用于管理非传染性,非瘤性,非脱血性疾病相关的脑膜炎.
- 为一致和有效的治疗方法提供框架.
- 用标准化的临床工具支持西班牙医疗保健系统.
主要方法:
- 将临床研究问题识别和重构为PICO格式 (患者,干预,比较,结果).
- 对现有的科学证据进行系统审查.
- 使用GRADE标准对证据进行分级 (建议评估,开发和评估的分级).
- 基于综合证据和专家共识的建议的制定.
主要成果:
- 制定了三个PICO问题,解决前性脑膜炎,非前性脑膜炎和带有斑点的脑膜炎.
- 总共制定了19个不同的建议.
- 建议来源于现有证据和专家共识的结合.
结论:
- 这些代表了西班牙风湿病学学会对这种特定类型的脑膜炎的首批官方建议.
- 这些指导方针旨在在西班牙医疗保健系统内直接应用.
- 其目的是加强治疗同质化和对非传染性紫外线炎患者的临床援助.
相关概念视频
Open Angle Glaucoma: Treatment
471
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
471
Angle Closure Glaucoma: Treatment
540
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
540
Pericarditis III: Medical Management
13
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
13
Myocarditis III: Medical Management
7
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
7
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
173
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
173
Inflammatory Bowel Disease IV: Pharmacological Management
135
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
135


